Phase 1 Endometrial Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have a specific type of lung cancer called non-squamous EGFR-Wt non-small cell lung cancer (a form of lung cancer where a particular gene marker, EGFR, is not mutated — confirm with trial site)
• People who have endometrial carcinoma (a cancer of the lining of the uterus)
• People who have ovarian cancer that has stopped responding to platinum-based treatment

Who may not be able to join:

• People who have cancer that has spread to the brain or spinal cord in a way that is not well controlled
• People who have a history of cancer spreading to the membranes surrounding the brain or spinal cord
• People who have an active infection — bacterial, viral, fungal, or parasitic — that is not under control
• People who have a known condition affecting the clear surface of the eye (cornea), or who have had a cornea transplant
• People who still have significant unresolved side effects from a previous cancer treatment
• People who have serious heart disease
• People whose heart's electrical activity shows a specific abnormality on an ECG reading (a QTcF measurement of 470 milliseconds or more — confirm with trial site)
• People who have a history of lung inflammation or scarring (pneumonitis or interstitial lung disease)
• People who are pregnant, breastfeeding, or planning to breastfeed during the study or within 30 days of the last dose of the study treatment

Important: Always verify eligibility with the trial site directly before applying.